Ratings BH Assurance

Equities

End-of-day quote Tunis Other stock markets 18:00:00 2024-04-21 EDT			5-day change	1st Jan Change
48.75 ^TND	-.--%		-.--%	-.--%

04-02	BH Assurance Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	BH Assurance Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Its low valuation, with P/E ratio at 8.66 and 8.36 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.63 for the 2024 fiscal year.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.

	1st Jan change	Capi.	ESG Refinitiv
BH ASSURANCE	-.--%	41.67M	-
CHUBB LIMITED	+21.36%	115B	C+
ALLIANZ SE	+10.77%	113B	B-
MARSH & MCLENNAN COMPANIES	+10.84%	104B	B
ZURICH INSURANCE GROUP LTD	+7.32%	74.85B	C+
HARTFORD FINANCIAL SERVICES GROUP (THE), INC.	+28.35%	30.51B	A-
TALANX AG	+10.98%	20.1B	A-
BB SEGURIDADE PARTICIPAÇÕES S.A.	+0.95%	13.15B	B-
POWSZECHNY ZAKLAD UBEZPIECZE? SPÓLKA AKCYJNA	+17.03%	12.19B	A-
ASR NEDERLAND N.V.	+14.43%	11.13B	A

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality